Skip to main content
. Author manuscript; available in PMC: 2007 Jan 31.
Published in final edited form as: Cancer Res. 2005 Jun 15;65(12):5238–5247. doi: 10.1158/0008-5472.CAN-04-3804

Table 1A.

Flow cytometric analysis of 7-AAD negatively gated, viable Colo−/Colo+ and CX−/CX+ carcinoma sublines

Marker Plasma membrane–positive cells,
% ± SE* (mean fluorescence intensity)
Colo− Colo+ CX− CX+
Hsp70 34 ± 5 (25 ± 5) 73 ± 5 (29 ± 7) 20 ± 6 (10 ± 4) 90 ± 8 (18 ± 3)
Bag-4 29 ± 11 (24 ± 2) 78 ± 1 (30 ± 5) 42 ± 10 (8 ± 1) 78 ± 2 (17 ± 1)
MHC I 99 ± 1 98 ± 2 98 ± 1 98 ± 2
*

Data represent mean percentages of Hsp70 (cmHsp70.1), Bag 4 (IMG-152), and MHC I (W6/32) plasma membrane-positively stained cells of three independent experiments ± SE.

Significantly different from the corresponding negative cell type (P < 0.01).

HHS Vulnerability Disclosure